Program Overview


ACCP gratefully acknowledges the 2022 Annual Meeting Program Committee, co-chaired by Oliver Grundmann, PhD, FCP & Joanna C. Masters, PharmD, FCP  as they have worked diligently on the 2022 program to ensure an outstanding, cutting-edge scientific meeting.


2022 Annual Meeting Program Committee

PROGRAM CO-CHAIRS

Oliver Grundmann, PhD, FCP, Clinical Professor, Medicinal Chemistry, Univ of Florida
Joanna C. Masters, PharmD, FCP, Director, Pharmacometrics & Clinical Pharmacology, Pfizer, Inc

COMMITTEE MEMBERS
  • Kacey Anderson, PhD
  • Kristina Brooks, PharmD
  • Jomy George, PharmD
  • Navin Goyal, PhD
  • Dionna Green, MD
  • Amalia Issa, PhD
  • Otito Iwuchukwu, PhD
  • Yi Ting (Kayla) Lien, PhD

  • Donald E. Mager, PharmD, PhD ex officio
  • Ahmed Othman, PhD
  • Natella Rakhmanina, MD
  • Arun Ram, MD
  • Mohamed Shebley, PhD
  • Zaid Temrikar, MS
  • Steven Tung, MD

2022 Annual Meeting Program educational courses will include presentations that span the breadth of current, relevant topics. In support of improving patient care, the American College of Clinical Pharmacology® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Continuing Education credit is provided to Attendees at no additional cost.

 

2022 ACCP Virtual Annual Meeting Program
(updated 09/22/2021)

SATURDAY, SEPTEMBER 24th

8:00 AM - 5:00 PM ET
• Quantitative Systems Pharmacology 101 Workshop: Concept & Applications in Clinical Drug Development for Students, Trainees & Early-stage Professionals

• Trends in Drug Development Workshop (separate registration required)

SUNDAY, SEPTEMBER 25th

8:00 - 9:30 AM ET
Plenary Session (TBD)

9:30 - 10:00 AM ET
Networking Break

10:00 - 11:30 AM ET
• SYM 1: Equity in Clinical Trial Research: Identifying, Preventing & Addressing Sex/Gender & Race/Ethnicity Disparities to Improve Medication Access

• SYM 2: Interactions between Uremic Toxins & Therapeutic Agents

11:30 AM - 1:30 PM ET
Lunch & Awards

1:30 - 3:00 PM ET
• SYM 3: The Importance of Studying Diverse Populations in Clinical Trials: Barriers & Opportunities Using Race & Ethnicity as Example

• SYM 4: Is it Time to Rethink for Assessing Renal Function in Drug Development & Beyond?

• Student, Trainee & Early-stage Professional Panel Discussion

3:00 - 3:30 PM ET
Networking Break

3:30 - 5:00 PM ET
• SYM 5: Hot Topics

• Student, Trainee & Early-stage Professional Podium Presentations & Networking

5:00 - 7:00 PM ET
Opening Reception, Exhibits & Poster Session 1

7:00 - 9:00 PM ET
PharmaFete Social

MONDAY, SEPTEMBER 26th

8:00 - 9:30 AM ET
• SYM 6: Assessing the Feasibility of Model-Informed Precision Dosing: A Point-counterpoint Debate (ACCP/ISoP SIG Joint Symposium)

• SYM 7: Clinical Pharmacology Considerations for Monoclonal Antibodies Developed to Combat COVID-19

9:30 - 10:00 AM ET
Networking Break

10:00 - 11:30 AM ET
Invited Keynote Presentation (TBD)

11:30 AM - 1:30 PM ET
Lunch & Awards

1:30 - 3:00 PM ET
• SYM 8: Part 1: Model-Informed Drug Development for Specific Populations, Current Status & Future Perspectives (ACCP/ISSX Joint Symposium)

• SYM 9: Impact of COVID-19 Pandemic on Clinical Trials: Challenges & Opportunities from Clinical Pharmacology Perspective

3:00 - 3:30 PM ET
Networking Break

3:30 - 5:00 PM ET
• SYM 8: Part 2: Model-Informed Drug Development for Specific Populations, Current Status & Future Perspectives (ACCP/ISSX Joint Symposium)

• SYM 10: Resilience During Crisis from the Frontline (ACCP/AAMC/CFAS Joint Symposium)

5:00 - 7:00 PM ET
Evening Reception, Exhibits & Poster Session 2

TUESDAY, SEPTEMBER 27th

8:00 - 9:30 AM ET
• SYM 11: Hot Topics

• SYM 12: Revisiting Oncology Dose Finding: Striking the Optimum Balance between Efficiency & Robustness

9:30 - 10:00 AM ET
Networking Break

10:00 - 11:30 AM ET
• SYM 13: Utilizing Quantitative Clinical Pharmacology & Interventional Pharmacoeconomics to More Efficiently Optimize Dose Regimens

• SYM 14: Drug-Drug Interactions in 65+: Are They Getting the Right Dose?

11:30 AM - 1:30 PM ET
Lunch & Annual Business Meeting

1:30 - 3:00 PM ET
• SYM 15: Substance Use Disorders, The Journal of Clinical Pharmacology Supplement Focusing on Cannabinoids, Prescription Drugs & Illicit Drugs, Dependence & Abuse

• SYM 16: Vaccine Development 101

3:00 - 3:30 PM ET
Networking Break

3:30 - 5:00 PM ET
• SYM 17: Utilizing Past & Present Big Data in Decision Making for Drug Development & Regulation